Two Thames Valley companies have recently received funding from Google and its parent company, Alphabet.
Harwell, Oxfordshire based Serelay was announced as one of the recipients of the third round of funding from the Digital News Initiative (DNI), a partnership between Google and news publishers in Europe to support high-quality journalism through technology and innovation. Serelay has developed technology for trusted media capture, making it easily accessible to both end users and any digital platform. Of the 988 projects submitted to the DNI, 107 projects in 27 countries were selected to be offered funding worth a total of €21,968,154.
Roy Azoulay, Founder & CEO of Serelay commented: “We are grateful for the vote of confidence by Google DNI fund as well its generous financial support which allowed us to turn an ambitious concept into a successful prototype. We have an exciting development roadmap for 2018, during which Serelay will also be supported by the European Space Agency, Innovate UK and CSIT Labs”
In addition, UK biotech firm Vaccitech has received funding through Google parent company Alphabet’s venture arm, GV, and through Sequoia Capital China. Vaccitech is a spin-out company from the University of Oxford’s Jenner Institute, one of the oldest and most renowned vaccine research centres in the world. The company is currently engaged in Phase Two clinical programs for universal influenza and prostate cancer.
Dr Tom Evans, CEO of Vaccitech, said: “With these funds we look forward to taking critical programs, which could improve the lives of millions of people, through to Proof of Concept studies.”← back to Blog